About PEIJIA-B Company

The company is a global provider of innovative medical products and solutions. We focus on China's high-growth interventional medical device market. Our products and products under development target large-scale, rapidly growing markets with insufficient penetration and high entry barriers, including the medical device market for transcatheter valve treatment and the medical device market for neurointerventional surgery. Our vision Become a patient-centered, innovative, and respected global high-tech medical enterprise. Our mission We are committed to providing products and solutions that are safe, effective and accessible to patients through continuous innovation to reduce the suffering of patients and improve their quality of life. Our product pipeline As of the date of this annual report, our product pipeline includes transcatheter valve therapy and neurological intervention products and products under development. In the transcatheter valve treatment business, we have two commercialized TAVR systems — TaurusOne and TaurusElite, three commercialized surgical accessories, and a number of products under development for aortic valve replacement, mitral and tricuspid valve replacement and repair at various stages of development. In the neurological intervention business, we have 14 commercialized products and various products under development at various stages of development, covering hemorrhagic, ischemic stroke and vascular pathways.